Published in Int J Nanomedicine on October 30, 2013
Physicochemical properties, cytotoxicity, and antimicrobial activity of sulphated zirconia nanoparticles. Int J Nanomedicine (2015) 0.80
Oxidative stress-mediated apoptosis induced by ethanolic mango seed extract in cultured estrogen receptor positive breast cancer MCF-7 cells. Int J Mol Sci (2015) 0.79
Induction of apoptosis and oxidative stress in estrogen receptor-negative breast cancer, MDA-MB231 cells, by ethanolic mango seed extract. BMC Complement Altern Med (2015) 0.75
Cytotoxicity and physicochemical characterization of iron-manganese-doped sulfated zirconia nanoparticles. Int J Nanomedicine (2015) 0.75
Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science (2001) 23.42
The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol (2008) 20.89
Apoptosis: a review of programmed cell death. Toxicol Pathol (2007) 17.92
Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science (1997) 16.09
Molecular characterization of mitochondrial apoptosis-inducing factor. Nature (1999) 14.41
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell (1993) 12.02
Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci U S A (1992) 8.87
The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature (1999) 7.85
How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol (2008) 6.02
Mitochondria as the central control point of apoptosis. Trends Cell Biol (2000) 5.91
Double identity for proteins of the Bcl-2 family. Nature (1997) 5.60
Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science (1993) 4.53
p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci U S A (1995) 4.22
Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr (1993) 3.89
Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem (1995) 3.79
Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med (1997) 3.74
Free radicals, antioxidants, and nutrition. Nutrition (2002) 3.66
Generation of reactive oxygen species by the mitochondrial electron transport chain. J Neurochem (2002) 3.61
Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev (2008) 3.34
Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes (2003) 2.96
Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol (2008) 2.95
Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng (2005) 2.81
Reactive oxygen species and programmed cell death. Trends Biochem Sci (1996) 2.68
Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med (2000) 2.52
Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic Biol Med (2002) 2.35
Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med (2009) 2.21
Control of mitochondrial permeability by Bcl-2 family members. Biochim Biophys Acta (2004) 2.00
Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique. Int J Hyperthermia (2005) 1.99
A COLORIMETRIC MICRO-METHOD FOR THE DETERMINATION OF GLUTATHIONE. Biochem J (1965) 1.90
Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines. Cancer Res (2002) 1.74
Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy. Biomaterials (2010) 1.49
The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells. Nanotechnology (2009) 1.38
Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles. Magn Reson Med (2003) 1.27
Selective cytotoxicity of goniothalamin against hepatoblastoma HepG2 cells. Molecules (2011) 1.20
Multiple actions of pifithrin-alpha on doxorubicin-induced apoptosis in rat myoblastic H9c2 cells. Am J Physiol Heart Circ Physiol (2006) 1.18
Oxidative stress mediated apoptosis induced by nickel ferrite nanoparticles in cultured A549 cells. Toxicology (2011) 1.16
Strong increase in hydroxy fatty acids derived from linoleic acid in human low density lipoproteins of atherosclerotic patients. Chem Phys Lipids (1998) 1.13
Cytotoxicity of nickel zinc ferrite nanoparticles on cancer cells of epithelial origin. Int J Nanomedicine (2013) 1.10
Biomarkers of oxidative stress and DNA damage in agricultural workers: a pilot study. Toxicol Appl Pharmacol (2007) 1.07
Cytochrome c activates K+ channels before inducing apoptosis. Am J Physiol Cell Physiol (2002) 0.99
Bok, Bcl-2-related Ovarian Killer, Is Cell Cycle-regulated and Sensitizes to Stress-induced Apoptosis. J Biol Chem (2006) 0.93
Synergistic effect of a combination of nanoparticulate Fe3O4 and gambogic acid on phosphatidylinositol 3-kinase/Akt/Bad pathway of LOVO cells. Int J Nanomedicine (2012) 0.82
The relationship between the nanostructure of titanium surfaces and bacterial attachment. Biomaterials (2009) 2.28
Endothelial and vascular smooth muscle cell function on poly(lactic-co-glycolic acid) with nano-structured surface features. Biomaterials (2004) 2.02
Reducing infections through nanotechnology and nanoparticles. Int J Nanomedicine (2011) 1.72
Selenium nanoparticles inhibit Staphylococcus aureus growth. Int J Nanomedicine (2011) 1.71
Selective bone cell adhesion on formulations containing carbon nanofibers. Biomaterials (2003) 1.57
Development of antiproliferative nanohybrid compound with controlled release property using ellagic acid as the active agent. Int J Nanomedicine (2011) 1.57
Antimicrobial applications of nanotechnology: methods and literature. Int J Nanomedicine (2012) 1.51
Nanobiomaterial applications in orthopedics. J Orthop Res (2007) 1.51
Controlled release of a plant growth regulator, alpha-naphthaleneacetate from the lamella of Zn-Al-layered double hydroxide nanocomposite. J Control Release (2002) 1.49
Biaxial strength of multilaminated extracellular matrix scaffolds. Biomaterials (2004) 1.49
Increased osteoblast and decreased Staphylococcus epidermidis functions on nanophase ZnO and TiO2. J Biomed Mater Res A (2006) 1.49
Using hydroxyapatite nanoparticles and decreased crystallinity to promote osteoblast adhesion similar to functionalizing with RGD. Biomaterials (2006) 1.45
The role of nanometer and sub-micron surface features on vascular and bone cell adhesion on titanium. Biomaterials (2008) 1.43
Enhanced fibronectin adsorption on carbon nanotube/poly(carbonate) urethane: independent role of surface nano-roughness and associated surface energy. Biomaterials (2007) 1.41
Comparison of in situ polymerization and solution-dispersion techniques in the preparation of Polyimide/Montmorillonite (MMT) Nanocomposites. Int J Mol Sci (2011) 1.39
Synthesis of nanocrystalline SnO(x) (x = 1-2) thin film using a chemical bath deposition method with improved deposition time, temperature and pH. Sensors (Basel) (2011) 1.38
Polymers with nano-dimensional surface features enhance bladder smooth muscle cell adhesion. J Biomed Mater Res A (2003) 1.37
Nano-structured polymers enhance bladder smooth muscle cell function. Biomaterials (2003) 1.34
Preparation of hippurate-zinc layered hydroxide nanohybrid and its synergistic effect with tamoxifen on HepG2 cell lines. Int J Nanomedicine (2011) 1.34
Nanometer surface roughness increases select osteoblast adhesion on carbon nanofiber compacts. J Biomed Mater Res A (2004) 1.31
Enhanced functions of osteoblasts on nanometer diameter carbon fibers. Biomaterials (2002) 1.29
Nanotechnology for regenerative medicine. Biomed Microdevices (2010) 1.27
The use of superparamagnetic nanoparticles for prosthetic biofilm prevention. Int J Nanomedicine (2009) 1.25
Green synthesis and characterization of silver/chitosan/polyethylene glycol nanocomposites without any reducing agent. Int J Mol Sci (2011) 1.25
Controlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (RBL-2H3) cells. Int J Nanomedicine (2012) 1.25
Nano rough micron patterned titanium for directing osteoblast morphology and adhesion. Int J Nanomedicine (2008) 1.24
Carbon nanofibers and carbon nanotubes in regenerative medicine. Adv Drug Deliv Rev (2009) 1.21
Nanotextured titanium surfaces for enhancing skin growth on transcutaneous osseointegrated devices. Acta Biomater (2009) 1.21
In vitro inhibition of histamine release behavior of cetirizine intercalated into Zn/Al- and Mg/Al-layered double hydroxides. Int J Mol Sci (2012) 1.21
Nanostructured polymer/nanophase ceramic composites enhance osteoblast and chondrocyte adhesion. Tissue Eng (2002) 1.21
Improved endothelial cell adhesion and proliferation on patterned titanium surfaces with rationally designed, micrometer to nanometer features. Acta Biomater (2007) 1.19
The influence of nano MgO and BaSO4 particle size additives on properties of PMMA bone cement. Int J Nanomedicine (2008) 1.17
Enhanced osteoblast functions on anodized titanium with nanotube-like structures. J Biomed Mater Res A (2008) 1.17
Bactericidal effect of iron oxide nanoparticles on Staphylococcus aureus. Int J Nanomedicine (2010) 1.17
Photocatalytic degradation of p-cresol by zinc oxide under UV irradiation. Int J Mol Sci (2011) 1.16
Synthesis, characterization, and antimicrobial properties of copper nanoparticles. Int J Nanomedicine (2013) 1.16
Increased osteoblast functions among nanophase titania/poly(lactide-co-glycolide) composites of the highest nanometer surface roughness. J Biomed Mater Res A (2006) 1.16
Diameter of titanium nanotubes influences anti-bacterial efficacy. Nanotechnology (2011) 1.15
Development of a controlled-release anti-parkinsonian nanodelivery system using levodopa as the active agent. Int J Nanomedicine (2013) 1.14
Accelerated chondrocyte functions on NaOH-treated PLGA scaffolds. Biomaterials (2005) 1.12
Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite. Int J Nanomedicine (2012) 1.12
Three-dimensional, nano-structured PLGA scaffolds for bladder tissue replacement applications. Biomaterials (2005) 1.11
Cytotoxicity of nickel zinc ferrite nanoparticles on cancer cells of epithelial origin. Int J Nanomedicine (2013) 1.10
Nanotechnology for bone materials. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 1.10
Enhanced osteoblast adhesion to drug-coated anodized nanotubular titanium surfaces. Int J Nanomedicine (2008) 1.09
Enhanced chondrocyte densities on carbon nanotube composites: the combined role of nanosurface roughness and electrical stimulation. J Biomed Mater Res A (2008) 1.09
TiO2 nanotubes functionalized with regions of bone morphogenetic protein-2 increases osteoblast adhesion. J Biomed Mater Res A (2008) 1.08
Sustained release formulation of an anti-tuberculosis drug based on para-amino salicylic acid-zinc layered hydroxide nanocomposite. Chem Cent J (2013) 1.08
Helical rosette nanotubes: a biomimetic coating for orthopedics? Biomaterials (2005) 1.08
Mechanism(s) of increased vascular cell adhesion on nanostructured poly(lactic-co-glycolic acid) films. J Biomed Mater Res A (2005) 1.07
Decreased fibroblast cell density on chemically degraded poly-lactic-co-glycolic acid, polyurethane, and polycaprolactone. Biomaterials (2004) 1.07
Biologically inspired rosette nanotubes and nanocrystalline hydroxyapatite hydrogel nanocomposites as improved bone substitutes. Nanotechnology (2009) 1.06
Arginine-glycine-aspartic acid modified rosette nanotube-hydrogel composites for bone tissue engineering. Biomaterials (2008) 1.05
Reduced adhesion of macrophages on anodized titanium with select nanotube surface features. Int J Nanomedicine (2011) 1.05
Greater osteoblast proliferation on anodized nanotubular titanium upon electrical stimulation. Int J Nanomedicine (2008) 1.04
Nanofunctionalized zirconia and barium sulfate particles as bone cement additives. Int J Nanomedicine (2010) 1.04
Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect. Int J Nanomedicine (2013) 1.03
Enhanced osteoblast adhesion on hydrothermally treated hydroxyapatite/titania/poly(lactide-co-glycolide) sol-gel titanium coatings. Biomaterials (2005) 1.03
Osteoblast function on nanophase alumina materials: Influence of chemistry, phase, and topography. J Biomed Mater Res A (2003) 1.02
Increased osteoblast functions in the presence of hydroxyapatite-coated iron oxide nanoparticles. Acta Biomater (2010) 1.01
Nanocrystalline hydroxyapatite/titania coatings on titanium improves osteoblast adhesion. J Biomed Mater Res A (2008) 1.00
Antituberculosis nanodelivery system with controlled-release properties based on para-amino salicylate-zinc aluminum-layered double-hydroxide nanocomposites. Drug Des Devel Ther (2013) 1.00
Decreased functions of astrocytes on carbon nanofiber materials. Biomaterials (2003) 0.99
Poly(lactic-co-glycolic acid): carbon nanofiber composites for myocardial tissue engineering applications. Acta Biomater (2011) 0.98
Increased chondrocyte adhesion on nanotubular anodized titanium. J Biomed Mater Res A (2009) 0.98
Anodization: a promising nano-modification technique of titanium implants for orthopedic applications. J Nanosci Nanotechnol (2006) 0.98
An overview of nano-polymers for orthopedic applications. Macromol Biosci (2007) 0.98
Enhanced functions of vascular cells on nanostructured Ti for improved stent applications. Tissue Eng (2007) 0.98
Decreased Staphylococcus aureus biofilm growth on anodized nanotubular titanium and the effect of electrical stimulation. Acta Biomater (2011) 0.97
Nanotechnology and biomaterials for orthopedic medical applications. Nanomedicine (Lond) (2006) 0.97
Increased osteoblast density in the presence of novel calcium phosphate coated magnetic nanoparticles. Nanotechnology (2008) 0.96
Nanotechnology controlled drug delivery for treating bone diseases. Expert Opin Drug Deliv (2009) 0.96
Nanobiotechnology: implications for the future of nanotechnology in orthopedic applications. Expert Rev Med Devices (2004) 0.96
Comparative study of Mg/Al- and Zn/Al-layered double hydroxide-perindopril erbumine nanocomposites for inhibition of angiotensin-converting enzyme. Int J Nanomedicine (2012) 0.95
Enhanced osteoblast adhesion on self-assembled nanostructured hydrogel scaffolds. Tissue Eng Part A (2008) 0.95
Greater osteoblast and endothelial cell adhesion on nanostructured polyethylene and titanium. Int J Nanomedicine (2010) 0.94
Electrically controlled drug release from nanostructured polypyrrole coated on titanium. Nanotechnology (2011) 0.94
Titanium surfaces with adherent selenium nanoclusters as a novel anticancer orthopedic material. J Biomed Mater Res A (2010) 0.94
The impact of diamond nanocrystallinity on osteoblast functions. Biomaterials (2009) 0.93
Biomimetic helical rosette nanotubes and nanocrystalline hydroxyapatite coatings on titanium for improving orthopedic implants. Int J Nanomedicine (2008) 0.93
Enhanced endothelial cell density on NiTi surfaces with sub-micron to nanometer roughness. Int J Nanomedicine (2008) 0.93
PLGA nanometer surface features manipulate fibronectin interactions for improved vascular cell adhesion. J Biomed Mater Res A (2007) 0.93
Decreased bacteria activity on Si₃N₄ surfaces compared with PEEK or titanium. Int J Nanomedicine (2012) 0.93
Nanomedicine: what's in a definition? Int J Nanomedicine (2006) 0.93
Nanometer polymer surface features: the influence on surface energy, protein adsorption and endothelial cell adhesion. Nanotechnology (2008) 0.93
Increased osteoblast adhesion on nanograined hydroxyapatite and partially stabilized zirconia composites. J Biomed Mater Res A (2006) 0.92
Successful transfer of plasmid DNA into in vitro cells transfected with an inorganic plasmid-Mg/Al-LDH nanobiocomposite material as a vector for gene expression. Nanotechnology (2008) 0.92
Anodized 20 nm diameter nanotubular titanium for improved bladder stent applications. Int J Nanomedicine (2011) 0.91
The role of polymer nanosurface roughness and submicron pores in improving bladder urothelial cell density and inhibiting calcium oxalate stone formation. Nanotechnology (2009) 0.91